大行評級|麥格理:下調新秀麗目標價至43.9港元 首季業績好壞參半
麥格理髮表研究報吿指,新秀麗首季業績好壞參半。期內收入按年升4.1%,較預測低5%,但經調整EBITDA利潤率為18.8%,勝於預期的18.6%。集團將今年收入增長指引由高個位數下調至低個位數。另外,集團已聘請顧問準備進行二次上市,但目前仍處於早期階段,將會在適當的時候更新情況。該行下調集團2024至26年的每年經調整淨收入預測2.4%,以反映預期收入下調。該行將其目標價由45港元下調至43.9港元,維持“跑贏大市”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.